Article info
PDFEpidemiology/health services research
Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
- Correspondence to Dr Paula L Thompson; pthompson{at}mapigroup.com
Citation
Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
Publication history
- Received July 25, 2016
- Revised September 24, 2016
- Accepted October 2, 2016
- First published December 13, 2016.
Online issue publication
January 27, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/